Harel Insurance Investments & Financial Services (HARL) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Oct, 2026Executive summary
9M.24 profit was NIS 736M vs NIS 213M; profit before tax was NIS 1,069M vs NIS 277M, supported by investment income and stronger segment results.
9M.24 adjusted profit from insurance, asset management and credit rose to NIS 1,216M from NIS 1,021M; underwriting profit increased to NIS 884M from NIS 682M.
Growth was led by health and non-life; life results faced war-related claims and PHI pressure, while Turkish operations were affected by inflation and higher reinsurance costs.
Financial highlights
Q3.24 comprehensive income attributable to shareholders was NIS 547M vs NIS 271M; 9M.24 was NIS 672M vs NIS 397M.
Q3 profit was NIS 379M vs NIS 304M; total comprehensive income was NIS 549M vs NIS 274M. 9M reported comprehensive income before tax was NIS 980M vs NIS 562M.
9M total income was NIS 20,872M vs NIS 18,431M; net investment profit and financing income rose to NIS 8,812M from NIS 5,275M.
AUM reached NIS 489.7B at September 30, 2024; premiums and deposits were NIS 31.2B for 9M.24.
Outlook and guidance
2026 targets include NIS 520B AUM, NIS 43.8B premiums and deposits, NIS 1.91B fee income, NIS 2,217M adjusted core profit and NIS 1,404M underwriting profit.
Targets assume a 3% real proprietary/Nostro yield; the 2026 adjusted ROE goal is 12.1%. Forecasts depend on strategic-plan execution, market and macroeconomic conditions, and regulation.
IFRS 17 and IFRS 9 are scheduled to apply from January 1, 2025, with transition at January 1, 2024; preliminary estimates remain subject to review and change.
Latest events from Harel Insurance Investments & Financial Services
- IFRS 17 moves long-term insurance profit recognition into a gradual CSM release.HARL
IFRS 17 presentation - NIS 785M underwriting improvement in 2023 supports ambitious 2026 profit and ROE targets.HARL
Strategy presentation - Q1 net loss was NIS 45m amid an investment-income rebound and mixed segment results.HARL
Q1 2023 - Investment income rebounded, but H1 still recorded a NIS 91m net loss.HARL
Q2 2023 - Comprehensive income recovered, but net profit fell amid war and deal uncertainty.HARL
Q3 2023 - Underwriting gains lifted adjusted pre-tax profit to NIS 1.41B in 2023.HARL
Q4 2023 - Investment gains and underwriting recovery lifted Q1 net profit to NIS 214M.HARL
Q1 2024 - H1 profit rebounded, while investment and liability effects weighed on comprehensive income.HARL
Q2 2024 - Net income more than doubled as insurance business pre-tax income reached NIS 680M.HARL
Q1 2025